Navigation Links
ATCC and Evercyte Form a Partnership to Develop and Distribute Immortalized Human Cells and Cell Lines
Date:12/3/2013

Manassas, VA (PRWEB) December 03, 2013

ATCC, the premier global biological materials resource and standards organization, and Evercyte GmbH, a proven developer of immortalized human cells, have entered into a strategic partnership to develop and distribute immortalized cell lines that retain key performance characteristics of primary cells. Immortalized primary cell lines enable scientists to have a sufficient supply of physiologically relevant cells for extended studies in biological, medical, pharmaceutical, cosmetic, and toxicological research.

The partnership brings together the expertise of both organizations. Evercyte systematically establishes and functionally characterizes immortalized human cell lines from specific tissues and donors. ATCC provides extensive cell manufacturing and testing capabilities to assure the cell lines are fully defined and meet quality standards. Together, the organizations are making these unique cell lines available to the scientific community through existing global distribution channels.

“At ATCC, we’ve set the standard for providing the largest and most diverse collection of authenticated biological materials to the scientific community since 1925,” said Sharon Challberg, Principal, Corporate Development at ATCC. “Our mission is to provide biological materials for the advancement and application of scientific knowledge. This strategic partnership with Evercyte expands our ability to do so through a series of unique immortalized cell lines.”

“A key success factor of this partnership is the strength of the technical teams at both ATCC and Evercyte, given the combined years of experience in cell line development, characterization, and manufacturing,” said Chengkang Zhang, Ph.D., the technical lead for this program at ATCC.

Johannes Grillari, CSO of Evercyte, said, “Our core expertise is to systematically establish and characterize innovative, immortalized human cell cultures for cell based assays in pharmaceutical, chemical, and cosmetic industries as well as in ecotoxicology. With ATCC as a partner, high quality large-scale production of immortalized cell material is assured. Our mutual customers can develop standardized, relevant and reproducible cell based model systems and assays. In addition, ATCC’s world-wide distribution network is a perfect match for Evercyte, especially in regard to customers in academia,” Dr. Grillari added.

For more information about immortalized cell lines from ATCC and Evercyte, please visit http://www.atcc.org.

About ATCC
ATCC serves and supports the scientific community with industry-standard products and innovative solutions. With the world’s largest and most diverse collection of human, animal and plant cell lines, molecular genomic tools, microorganisms and biological products, ATCC is a trusted biological resource for the worldwide research community. Together, the people of ATCC share in its mission to acquire, authenticate, preserve, develop, and distribute biological materials and information for the advancement of scientific knowledge. ATCC is a non-profit organization with headquarters in Manassas, VA.

About Evercyte
By developing immortalized cells and cell lines that retain their parental characteristics, Evercyte seeks to accelerate drug discovery and development. Evercyte produces and delivers single immortalized cell strains, including mesenchymal stem cells that can be differentiated to the cell type of interest; cell panels with cell strains derived from different tissues or from donors of various health statuses; and as a service, offers customer- tailored immortalized cell strain development as well as cell based assay development. Evercyte is a spin-off company of the Department of Biotechnology, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11373736.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fertility Centers of New England Announces Partnership with CapexMD Fertility Financing
2. CESI Announces Partnership with Visiting Angels Home Care Agency to Address Financial Needs of A Growing, Aging Population
3. Progressive Dental Marketing CEO Cites Mutual Benefits of Strategic Referral Partnerships
4. Georgetown University 50-State Report Finds More Children Have Health Coverage - Attributes Gains to Successful Federal State Partnership Programs Medicaid and CHIP
5. Health Data Intelligence Announces Strategic Partnership with Predictive Analytics Technology Leader Analytics Inside
6. PolyU Gears Up for Aviation Services Research in Partnership with Boeing
7. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
8. BeachLifestyle and The Total Education Network Announce Their Partnership as the Simply G Media Network
9. NBA Basketball Star Stephen Curry Extends Partnership with Zamst to Stabilize Ankle
10. Mission: Medical Spanish - Canopy Apps & AMSA Partnership to Drive Medical Spanish Training at All 173 Medical Schools
11. Voices Against Brain Cancer to Host Annual “Join the Voices! Run/Walk” in Partnership with New York Road Runners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. Jessica Barron, of ... is now accepting new dental patients and families in the North Metro Denver area. ... services from cleanings to cosmetic dentistry, and all in the most relaxing environment. , ...
(Date:2/10/2016)... Boston, MA (PRWEB) , ... February 10, 2016 , ... ... light switch, and brings pain that is often severe, with intense swelling and redness. ... more than eight million people, but older adults are the most susceptible, according to ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... measure change in their patients. Research shows that the Goal Attainment Scale (GAS) ... therapists overcome this challenge and learn more about the Goal Attainment Scale, Education ...
(Date:2/10/2016)... MD (PRWEB) , ... February 10, 2016 , ... ... to make Everseat digital self-scheduling readily available to physicians. The integration ... patients can find and select appointments via Everseat’s free mobile app. , The ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... February 10, 2016 --> ... research report "Pharmaceutical Packaging Equipment Market by Package Type ... Serialization), by Product Type (Tablet, Powder, Cream, Syrup, Aseptic ... MarketsandMarkets, studies the global market during the forecast period of ... at a CAGR of 6.9% during the forecast period ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
(Date:2/10/2016)... 10, 2016 --> ... Therapeutics and Companion Diagnostic Market to 2019 - ... Environment" research report indicates that the core personalized ... by 2020 growing at a CAGR of 8.74%. ... and targeted therapeutics and is dominated by oncology, ...
Breaking Medicine Technology: